Rua Bioscience Limited logo

Results of 2024 Annual Shareholders' Meeting

AGM4 November 2024RUAHealthcare

FOR PUBLIC RELEASE
NZX Limited

Wellington


Monday, 4 November 2024


Results of Rua Bioscience Limited’s 2024 Annual Shareholders’ Meeting


At Rua Bioscience’s virtual Annual Shareholders’ Meeting held online earlier today, shareholders were asked to vote on

two ordinary resolutions which were supported by the Board. As required by NZX listing rule 6.1, all voting was

conducted by a poll. The resolutions passed by shareholders were as follows:


• That the Board be authorised to fix the auditor’s remuneration.

• That the Directors are authorised to issue up to 37,311,522 new ordinary fully paid shares in the Company

(New Shares) on the following terms:

(a) The New Shares may be issued to any person subject to the Company complying with the requirements of

the Financial Markets Conduct Act 2013 and the NZX Listing Rules in relation to any such issue.

(b) The New Shares may be issued through a single placement of up to 37,311,522 New Shares or via separate

placements of up to 37,311,522 New Shares in aggregate.

(c) Each New Share shall be issued at an issue price of not less than $0.03.

(d) The New Shares may be issued at any time during the course of the 12 month period following the passing

of this resolution.

(e) The New Shares, when issued, shall rank pari passu (equally) with all existing ordinary shares in the

Company.


Detail of the total number of votes cast in person or by a proxy holder are:


Resolution For Against Abstain

That the Board be authorised to fix the

auditor’s remuneration.


25,594,722

97.56%

641,089

2.44%

298,484

That the Directors are authorised to issue

up to 37,311,522 new ordinary fully paid

shares in the Company (New Shares).

25,266,241

96.18%


1,002,879

3.82%


265,175


Authority for this announcement

Name of person authorised to make this

announcement

Paul Naske, Chief Executive Officer

Contact person for this announcement Paul Naske, Chief Executive Officer

Contact phone number +64 21 445 154

Contact email address paul.naske@ruabio.com

Date of release through MAP 4 November 2024


PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com


ASM Voting Results

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.